Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Reitz

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Current Opinion in Drug Discovery & Development|August 4, 2009
Recent advances in traceless linkersA B Reitz
Organic Letters|March 27, 2001
Synthesis of an eight-membered cyclic pseudo-dipeptide using ring closing metathesisC J Creighton, A B Reitz
Journal of Medicinal Chemistry|February 2, 1999
Pharmacological treatment of obesity: therapeutic strategiesC P Kordik, A B Reitz
European Journal of Drug Metabolism and Pharmacokinetics|February 25, 2005
Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolitesW N Wu, L A McKown, A B Reitz
European Journal of Drug Metabolism and Pharmacokinetics|February 25, 2005
Metabolism of the new nonbenzodiazepine anxiolytic agent, RWJ-51204, in mouse, rat, dog, monkey and human hepatic S9 fractions, and in rats, dogs and humansW N Wu, L A McKown, A B Reitz
European Journal of Drug Metabolism and Pharmacokinetics|January 28, 2004
Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat--API-MS/MS identification of metabolitesW N Wu, L A McKown, A B Reitz
Journal of the American Chemical Society|December 20, 2011
Correction. stereochemistry of the wittig reaction. Effect of nucleophillic groups in phosphonium ylideB E Maryanoff, A B Reitz, B A Duhl-Emswiler
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2000
In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolitesW N Wu, L A McKown, M D Moyer, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2000
Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptorJ Lee, C B Davis, R A Rivero, et al.
Journal of the American Chemical Society|December 14, 2001
Conformational analysis of the eight-membered ring of the oxidized cysteinyl-cysteine unit implicated in nicotinic acetylcholine receptor ligand recognitionC J Creighton, C H Reynolds, D H Lee, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current Opinion in Drug Discovery & Development|August 4, 2009
Recent advances in traceless linkersA B Reitz
Organic Letters|March 27, 2001
Synthesis of an eight-membered cyclic pseudo-dipeptide using ring closing metathesisC J Creighton, A B Reitz
Journal of Medicinal Chemistry|February 2, 1999
Pharmacological treatment of obesity: therapeutic strategiesC P Kordik, A B Reitz
European Journal of Drug Metabolism and Pharmacokinetics|February 25, 2005
Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolitesW N Wu, L A McKown, A B Reitz
European Journal of Drug Metabolism and Pharmacokinetics|February 25, 2005
Metabolism of the new nonbenzodiazepine anxiolytic agent, RWJ-51204, in mouse, rat, dog, monkey and human hepatic S9 fractions, and in rats, dogs and humansW N Wu, L A McKown, A B Reitz
European Journal of Drug Metabolism and Pharmacokinetics|January 28, 2004
Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat--API-MS/MS identification of metabolitesW N Wu, L A McKown, A B Reitz
Journal of the American Chemical Society|December 20, 2011
Correction. stereochemistry of the wittig reaction. Effect of nucleophillic groups in phosphonium ylideB E Maryanoff, A B Reitz, B A Duhl-Emswiler
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2000
In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolitesW N Wu, L A McKown, M D Moyer, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2000
Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptorJ Lee, C B Davis, R A Rivero, et al.
Journal of the American Chemical Society|December 14, 2001
Conformational analysis of the eight-membered ring of the oxidized cysteinyl-cysteine unit implicated in nicotinic acetylcholine receptor ligand recognitionC J Creighton, C H Reynolds, D H Lee, et al.
Pageof 4